Gestalt Diagnostics
Latest round
- Series A
Last raised
- Apr 2025
Total raised
- $7.5M
Investors
- 5
About Gestalt Diagnostics
Gestalt Diagnostics, founded in 2017 in Spokane, US, provides digital pathology solutions that streamline laboratory processes.Gestalt specializes in advanced digital pathology solutions that enhance the workflow of pathology laboratories. Their flagship product, PathFlow®, is a sophisticated software platform that integrates with existing laboratory information systems (LIS) to provide a streamlined, fully interoperable workflow. This solution accommodates the needs of a diverse client base, including health systems, laboratories, and hospitals, by improving the speed and accuracy of disease diagnosis. PathFlow® leverages a widely adopted radiology workflow engine that supports over 13 million reads per year, facilitating efficient case management across multiple locations. The company's services encompass installation, implementation, training, and ongoing support, ensuring that clients can maximize the capabilities of their digital pathology systems.Gestalt generates revenue primarily through subscriptions and service agreements associated with its digital pathology solutions, including the PathFlow® product. Business transactions typically involve health systems, laboratories, and hospitals entering into contracts for software licenses and support services. Clients pay for the implementation of the PathFlow® system, which includes a comprehensive onboarding process, followed by ongoing service fees for maintenance and support. The company’s revenue model is structured around providing tailored solutions and services that address specific workflow needs within the pathology sector.S. Food and Drug Administration for its digital pathology platform. Gestalt aims to launch new products designed to integrate advanced AI functionalities, targeting new markets in North America and Europe by the end of 2026.
Who invested in Gestalt Diagnostics
5 investors across 1 round
See all investors in Gestalt Diagnostics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 28, 2025
Amount
$7.5M
Investors
Questions about Gestalt Diagnostics
Who invested in Gestalt Diagnostics?
Gestalt Diagnostics has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Gestalt Diagnostics raised?
Gestalt Diagnostics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Gestalt Diagnostics last raise money?
Gestalt Diagnostics's most recent round on record is a Series A, in Apr 2025.
What does Gestalt Diagnostics do?
Gestalt Diagnostics, founded in 2017 in Spokane, US, provides digital pathology solutions that streamline laboratory processes.
Where is Gestalt Diagnostics headquartered?
Gestalt Diagnostics is headquartered in Spokane, US.
Which VCs invest in companies like Gestalt Diagnostics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back software companies at Gestalt Diagnostics's stage. Their profiles are linked below.
VCs backing software startups at Series A
Raising like Gestalt Diagnostics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.